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Non-coding RNAs (ncRNAs) have long been recognized at imprinted gene loci and pro-
vided early paradigms to investigate their functions and molecular mechanisms of action.
The characteristic feature of imprinted genes, their monoallelic, parental-origin-dependent
expression, is achieved through complex epigenetic regulation, which is modulated by ncR-
NAs.This minireview focuses on two imprinted gene clusters, in which changes in ncRNA
expression contribute to human disorders. At theGNAS locus loss ofNESP RNA can cause
autosomal dominant Pseudohypoparathyroidism type 1b (AD-PHP-Ib), while at the SNRPN-
UBE3A locus a long ncRNA and processed snoRNAs play a role in Angelman-Syndrome
(AS) and Prader–Willi-Syndrome (PWS). The ncRNAs silence overlapping protein-coding
transcripts in sense or anti-sense orientation through changes in histone modifications
as well as DNA methylation at CpG-rich sequence motifs. Their epigenetic modulatory
functions are required in early development in the pre-implantation embryo or already in
the parental germ cells. However, it remains unclear whether the sequence homology-
carrying ncRNA itself is required, or whether the process of its transcription through other
promoters causes the silencing effect.
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Imprinted gene loci provided early model systems, in which non-
coding RNAs (ncRNAs) have been investigated (Barlow, 2011;
Ferguson-Smith, 2011). Imprinted genes are defined as being
monoallelically expressed dependent on their parental origin.
During the mammalian imprinting process, epigenetic marks are
established in the female or male germlines at imprinting control
regions (ICRs), which results in the silencing of one parental allele
in somatic cells of the offspring. A common feature of imprinted
genes is their occurrence in clusters, whereby one ICR regulates
the monoallelic expression of several neighboring genes, although
single units of an imprinted gene and associated retrogene have
also be identified (Cowley and Oakey, 2010). Imprinted gene clus-
ters often contain ncRNAs, which are now increasingly recognized
for their regulatory effects on nearby imprinted protein-coding
genes. This minireview will focus on the GNAS and SNRPN-
UBE3A imprinting clusters, in which disturbances of the ncRNAs
are associated with human hereditary disorders. Functions of ncR-
NAs at other clusters have been covered in recent excellent reviews
(Barlow, 2011; Ferguson-Smith, 2011; Pauler et al., 2012).
ROLES OF NON-CODING RNAs AT THE GNAS LOCUS AND
THEIR INVOLVEMENT IN AD-PHP-Ib
The roles of ncRNAs at the complex imprinted Gnas locus
(Figure 1A) have become more evident through recent studies
in human and mouse (Williamson et al., 2004, 2006, 2011; Bastepe
et al., 2005; Liu et al., 2005a; Chotalia et al., 2009; Chillambhi
et al., 2010). The locus, which is largely conserved between both
species, consists of two main protein-coding transcripts (Gnas and
Gnasxl) and two regulatory non-coding transcripts termed Nespas
and Exon 1A (EXON A/B in human). A fifth transcription unit,
Nesp, exerts a dual function within the locus through epigeneti-
cally regulating other transcripts and by encoding a protein (see
below; Ischia et al., 1997; Plagge et al., 2005; Chotalia et al., 2009;
Fröhlich et al., 2010).Gnas encodes Gαs, theα-stimulatory subunit
of trimeric G-proteins, which mediates signal transduction from
seven-transmembrane receptors to adenylate cyclase (Weinstein
et al., 2001; Plagge et al., 2008). In some cell types, e.g., renal proxi-
mal tubules, brain subregions, thyroid, pituitary somatotroph cells
among others, Gnas is preferentially or exclusively expressed from
the maternally inherited allele (Plagge et al., 2008; Chen et al., 2009;
Zazo et al., 2011). Defects in Gnas expression from the maternal
allele can, therefore, disrupt various hormone signaling pathways,
which leads to a range of disease symptoms termed “Pseudohy-
poparathyroidisms (PHP)” with or without “Albright’s Heredi-
tary Osteodystrophy (AHO).” Typically, these comprise resistance
to parathyroid hormone, thyroid stimulating hormone, growth
hormone releasing hormone, gonadotrophins, and α-melanocyte
stimulating hormone (Plagge et al., 2008; Chen et al., 2011; Man-
tovani, 2011). The molecular defects causing PHP/AHO can be
categorized into two types: (a) mutations in the coding exons of
GNAS or (b) epigenetic changes at the differentially methylated
regions (DMRs) of theGNAS locus (Figure 1A). Maternally inher-
ited coding exon mutations invariably lead to a severe combination
of many PHP/AHO features, while epigenetic changes often only
result in a limited spectrum of hormone resistance symptoms,
mainly parathyroid hormone resistance (then also termed PHP-
Ib; de Nanclares et al., 2007; Mariot et al., 2008; Kelsey, 2010;
Mantovani et al., 2010; Mantovani, 2011).
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FIGURE 1 | Simplified schemes of the Gnas and Snrpn-Ube3a imprinted
loci. The features of the maternal and paternal alleles are indicated in red and
blue, respectively. Genes or transcripts are named in the central part. Arrows
mark transcription start sites and undulating lines ncRNAs. Open and filled
boxes represent non-coding and coding exons, respectively, while black boxes
indicate silenced genes. Differentially methylated regions (DMRs) of DNA are
marked by MMM. (A) For the Gnas locus the alternatively spliced coding
transcripts and proteins are named above and below the alleles. DMRs at
Nespas and Exon 1A (EXON A/B in human) are established in the maternal
germline, while methylation at Nesp occurs during early embryonic
development. Gnas is expressed biallelically, but is silenced on the paternal
allele in some tissues (hatched box), in which Exon 1A shows comparatively
high expression levels (interrupted undulating line). Nesp represents a coding
transcript (ORF limited to Nesp exon 2), but a regulatory RNA is initiated from
a separate promoter in oocytes (red undulating line). Nespas is expressed
from the unmethylated imprinting control region (ICR) of the locus. (B) The
Snrpn-Ube3a imprinting cluster contains several genes (represented by
single-exon boxes) that show monoallelic expression in brain. Ube3a is
biallelically expressed in most tissues, but silenced on the paternal allele in
neurons (hatched box). The Snrpn long ncRNA occurs in multiple, variably
processed forms, including brain-specific variants that contain upstream
promoters/exons (U-exons) and sequences overlapping with Ube3a
(interrupted undulating lines). Snord115 and Snord116 represent clusters of
C/D box snoRNAs, which are generated from the Snrpn ncRNA. The bipartite
ICR of the human locus is indicated as AS-IC and PWS-IC, the latter being
conserved in mouse around the main Snrpn start site. C15orf2 is not present
in the murine locus. Somatic DMRs at Ndn and Mkrn3 are established during
development. Transcription from U-exons occurs in the female germline in
growing oocytes (red undulating line) and is involved in the establishment of
methylation at the PWS-IC.
The epigenetic abnormalities associated with PHP consist of
changes in DNA methylation at DMRs as well as changes in ncRNA
expression. Furthermore, these can occur in a familial pattern
upon maternal inheritance of a mutation, i.e., autosomal dom-
inant pseudohypoparathyroidism type 1b (AD-PHP-Ib; Bastepe
et al., 2003, 2005), or sporadically, in which case the molecular
cause is unknown, but most likely due to abnormalities in epi-
genetic regulators that act at several imprinted loci (Liu et al.,
2005b; Linglart et al., 2007; Fernandez-Rebollo et al., 2011; Manto-
vani, 2011; Maupetit-Mehouas et al., 2011). A common epigenetic
change in AD-PHP-Ib is the loss of maternal allele-specific methy-
lation at the EXONA/B DMR, located a few kb upstream of GNAS
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exon 1 (Figure 1A). Interestingly, on the unmethylated paternal
allele this exon acts as the start site of a ncRNA, which is tran-
scribed across the GNAS promoter in the same direction (Liu
et al., 2000a,b). Evidence from AD-PHP-Ib patients as well as
mouse models indicates that the expression levels of the two tran-
scripts, EXON A/B and GNAS, are oppositely regulated in cis. On
the maternal allele methylation across EXON A/B inhibits expres-
sion of the ncRNA, while the downstream GNAS promoter drives
the expression of the coding RNA (Liu et al., 2000a,b). On the
paternal allele lack of methylation allows EXON A/B expression,
while the GNAS promoter is suppressed in at least some cell types,
i.e., GNAS expression becomes imprinted, for example in renal
proximal tubules. In AD-PHP-Ib patients two types of deletion
mutations upstream of GNAS result in loss of methylation at the
EXON A/B DMR. One of these comprises a 1.3 kb region in the
neighboring gene STX16 ∼220 kb upstream of GNAS (Bastepe
et al., 2003; Linglart et al., 2005), and the other deletion affects
the most 5′ region within the complex GNAS locus (i.e., NESP
and NESPAS exons; Bastepe et al., 2005; Chillambhi et al., 2010;
Richard et al., 2012). For the latter type of deletion it has been
shown that the loss of methylation at EXON A/B is not only asso-
ciated with a loss of GNAS expression, but also with an increase
in the levels of the non-coding EXON A/B RNA (Bastepe et al.,
2005; Fröhlich et al., 2010). This raises the question of whether
the EXON A/B RNA, or the process of its transcription, regulates
GNAS expression. Further insights have been provided recently
through a mouse model, in which the Exon 1A RNA has been
truncated by insertion of a polyadenylation cassette (Eaton et al.,
2012). Paternal inheritance of this allele results in early termi-
nation of Exon 1A transcription, thus avoiding extension across
the downstream Gnas promoter region. DNA methylation across
the Exon 1A DMR is not changed in this model. However, the
expression of Gnas becomes up-regulated in tissues where it is
normally imprinted and repressed (and in which normally com-
paratively high levels of Exon 1A RNA are found; Eaton et al.,
2012). These observations favor a mechanism, whereby the non-
coding Exon 1A RNA, or the process of its transcription through
the Gnas promoter, inhibits the expression of the latter (tran-
scriptional interference), although alternative mechanisms (e.g.,
impairment of a silencer element for Gnas in the Exon 1A region)
cannot be excluded at this stage (Liu et al., 2000a; Eaton et al.,
2012).
In contrast to the Exon 1A transcript, the Nespas ncRNA func-
tions in an anti-sense orientation, to counter-regulate, and silence
the transcription of the Nesp55 coding RNA (Hayward and Bon-
thron, 2000; Wroe et al., 2000; Williamson et al., 2011). Nespas is
expressed from a separate promoter, which is located upstream of
Exon 1A and Gnas in the imprinting control center (ICR) of the
locus (Figure 1A; Williamson et al., 2006). It is transcribed in the
opposite direction of Exon 1A and Gnas and from the paternal
allele only. Its promoter is methylated on the maternal allele (Hay-
ward and Bonthron, 2000; Wroe et al., 2000; Williamson et al.,
2002). The role of the Nespas ncRNA was investigated using a
polyadenylation cassette again, to terminate the transcript a short
distance downstream of its initiation site (Williamson et al., 2011).
The authors showed that the truncated RNA had lost its anti-
sense silencing function for Nesp on the paternal allele. The DNA
methylation at the Nesp promoter on the paternal allele, which
is normally established during early embryogenesis, was lost and
Nesp became biallelically expressed. A second, hypomorphic Nes-
pas mutant (>90% loss of RNA levels, but no truncation) revealed
further insights into the mechanisms, by which the ncRNA silences
Nesp (Williamson et al., 2011). In this model DNA methylation on
the paternal allele of the Nesp DMR was also lost, but, in contrast
to the truncation model, expression of Nesp RNA was only par-
tially up-regulated. The reason for the different levels of induction
of Nesp transcription in the Nespas truncation vs. hypomorph
model was found to be related to histone modifications. While
the activating histone mark H3K4me3 is usually depleted at the
Nesp promoter on the paternal allele, increased levels were found
in both Nespas mutants, in line with Nesp transcriptional activa-
tion. Moreover, the H3K4me3 levels correlated with the degree
of transcriptional activation of Nesp as these were higher in the
Nespas truncation model (Williamson et al., 2011). Thus, under
normal conditions Nespas anti-sense transcription through the
Nesp promoter results in low H3K4me3 levels and suppression of
Nesp. Furthermore, the increased H3K4me3 levels in both Nespas
mutants are a likely cause for the lack of DNA methylation at the
Nesp DMR, since this histone modification is incompatible with
the action of the DNA methyltransferases Dnmt3a and 3L (Ooi
et al., 2007; Zhang et al., 2010). Other changes in histone marks
of both Nespas mouse models included a depletion of repressive
H3K9me3 downstream of the Nesp start site and a depletion of
the transcription elongation mark H3K36me3 upstream of Nesp,
which is consistent with up-regulation of Nesp and loss of Nespas
transcription, respectively, on the paternal allele (Williamson et al.,
2011). Overall, these findings indicate a major role for the non-
coding anti-sense RNA Nespas (or for its transcription process)
in mediating the silencing and stable suppression of Nesp in cis
through low levels of H3K4me3 and, consequently, DNA methyla-
tion via Dnmt3a/L. The attraction of histone modifying enzymes,
e.g., a histone demethylase, through the ncRNA appears to be a
likely molecular mechanism. Whether the changes of Nespas and
Nesp expression on the paternal allele of these mouse models fur-
ther affect the downstream Exon 1A and Gnas transcription units,
potentially leading to loss of imprinting of Gnas as described in
the Nespas ICR deletion mice, remains to be analyzed (Williamson
et al., 2006, 2011).
The theme of epigenetic regulation through RNAs (or through
the process of their transcription across other promoters) extends
to a third RNA of the Gnas locus, namely the protein-coding Nesp
(Ischia et al., 1997; Plagge et al., 2005; Chotalia et al., 2009). Dual
functions as a coding and ncRNA are unusual, but have recently
been described in several cases (Cooper et al., 2011; Kageyama
et al., 2011). The regulatory role of Nesp occurs in the female
germline in growing oocytes at postnatal stages when maternal
DNA methylation imprints are established at the Nespas ICR and
Exon 1A germline DMR (Chotalia et al., 2009). At this stage, an
oocyte-specific promoter drives the transcription of Nesp, which
extends through all other promoters and exons of the Gnas locus
(Figure 1A). When a polyadenylation/transcriptional termination
cassette was used to truncate the Nesp RNA shortly after its single-
exon open reading frame on the maternal allele, the DNA methy-
lation marks at the Nespas ICR and Exon 1A germline DMR failed
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to be established (Chotalia et al., 2009). Offspring that inherited
this truncation maternally showed epigenetic and transcriptional
patterns on the maternal chromosome in somatic tissues that
resembled those normally found on the paternal chromosome,
i.e., loss of DNA methylation was associated with expression of
the Nespas, Gnasxl, and Exon 1A transcripts. Consequently, tran-
scription of Nesp and Gnas (in imprinted tissues) became silenced
and the somatic Nesp DMR methylated on the maternal chro-
mosome (Chotalia et al., 2009). The consequences of the Nesp
truncation are, therefore, very similar to the NESP deletion muta-
tions found in patients with AD-PHP-Ib described above (Bastepe
et al., 2005; Chillambhi et al., 2010; Richard et al., 2012) and to
the mouse Nesp deletion model (Fröhlich et al., 2010). The com-
parison of these various mutants emphasizes the importance of
the process of transcription (or generation of overlapping RNA)
for establishing epigenetic modifications, which then last through-
out development. Regarding details of the molecular mechanisms
involved, several possibilities have been discussed and a crucial role
of histone modifications/modifying enzymes and their interaction
with DNA methyltransferase and/or RNA Polymerase complexes
appear most likely (Smallwood and Kelsey, 2012).
ROLES OF THE LONG ncRNA SNRPN AT THE PWS/AS LOCUS
Another cluster of imprinted genes that is regulated by a large
∼0.5–1.0 Mb ncRNA, termed SNRPN, is located on human chro-
mosome 15q11-13 and is largely conserved on mouse chromo-
some 7 (Figure 1B; Landers et al., 2004; Buiting, 2010). In humans,
the locus is associated with the neurogenetic imprinting dis-
orders Prader–Willi-Syndrome (PWS) and Angelman-Syndrome
(AS; Buiting, 2010; Mabb et al., 2011). AS is caused by loss of
expression of UBE3A from the maternal allele. UBE3A encodes
an E3 ubiquitin ligase, which is only imprinted in brain and
biallelically expressed in other tissues. Among other symptoms,
the disorder is characterized by developmental delays, intellec-
tual disability, and behavioral abnormalities (happy demeanor;
Mabb et al., 2011). By contrast, the symptoms of PWS, which
include neonatal hypotonia, feeding difficulties, and growth retar-
dation followed from early childhood onward by hyperphagia,
severe obesity, hypogonadism, and behavioral abnormalities, is
caused by loss of expression of several paternally expressed genes
of the locus (Buiting, 2010). Mouse models and human genetic
studies indicate that the genes NECDIN (NDN ), MAGEL2, and
parts of the long ncRNA (lncRNA) SNRPN contribute to this
complex disorder (Figure 1B; Gerard et al., 1999; Muscatelli
et al., 2000; Kozlov et al., 2007; Sahoo et al., 2008; de Smith
et al., 2009; Duker et al., 2010). The lncRNA SNRPN can be
processed and spliced in many ways and is expressed in most
tissues. Some of its transcript variants are neuron-specific, ini-
tiated at separate upstream exons (U-exons), and overlap anti-
sense with Ube3a (then also termed UBE3A-ATS; Bressler et al.,
2001; Runte et al., 2001; Yamasaki et al., 2003; Landers et al.,
2004; Le Meur et al., 2005). The U-exon/SNRPN/UBE3A-ATS
lncRNA has a crucial role in silencing UBE3A on the paternal
allele in neural tissue. The SNRPN main transcriptional start
site is located within the PWS-IC, a 4.3 kb (or 6.0 kb in mouse)
region, which remains unmethylated on the paternal allele and
is thought to contain an activator function for all paternally
expressed genes, including those located upstream of the lncRNA
(Figure 1B; Buiting, 2010; DuBose et al., 2011). This function
of the PWS-IC, to guarantee paternal gene expression, appears
to be required at a critical time point during pre-implantation
development, but not anymore at later stages, e.g., in neuronal
precursor cells (DuBose et al., 2012; Rabinovitz et al., 2012).
It remains to be clarified whether transcription of the Snrpn
lncRNA in early embryos might attract histone modifications,
which consequently lead to the permanent setting of all epi-
genetic marks of the paternal allele (Makedonski et al., 2005;
Mabb et al., 2011), resulting not only in activation of paternally
expressed genes, but also silencing of Ube3a in brain. Alternatively,
Ube3a might be silenced directly on the level of transcriptional
processes, since no differential DNA methylation occurs at this
gene (Mabb et al., 2011). A truncated Ube3a-ats RNA that still
contains the Snord RNA clusters (Figure 1B; see below), but does
not overlap with Ube3a anymore, lost its silencing function on the
latter in a cell culture model, indicating that the lncRNA needs
to contain anti-sense sequences to Ube3a or that the process of
transcription through the coding gene is required (Meng et al.,
2012).
The SNRPN lncRNA has a unique additional feature as
it contains two large clusters of small nucleolar RNAs (C/D
box snoRNAs), termed SNORD115 and SNORD116, which are
predominantly expressed in the brain and, in the case of
SNORD116, contribute to many of the PWS symptoms (Sahoo
et al., 2008; de Smith et al., 2009; Duker et al., 2010; Bortolin-
Cavaille and Cavaille, 2012). The evidence from human PWS
patients carrying microdeletions of the SNORD116 cluster has
been confirmed in mice with targeted deletion of the corre-
sponding elements, although the murine phenotype is largely
restricted to the neonatal hypotonia and growth retardation
of PWS and does not reproduce the obesity and infertility
found in adult PWS patients (Skryabin et al., 2007; Ding et al.,
2008). The Snord115 and 116 clusters are processed from Snrpn
and show the typical features of C/D box snoRNAs. How-
ever, their precise molecular functions remain elusive as they
do not show the usual anti-sense sequence characteristics to
ribosomal or spliceosomal RNAs (Bortolin-Cavaille and Cavaille,
2012).
In humans, the expression of the SNRPN lncRNA from the
PWS-IC is itself regulated by a second element, which is located
∼30 kb upstream and termed AS-IC (Figure 1B; Buiting, 2010;
Mabb et al., 2011). The AS-IC mediates methylation of the PWS-
IC on the maternal chromosome and silencing of SNRPN, which
in turn allows UBE3A expression. The AS-IC element was shown
to bind a number of proteins, including transcription factors, but
is not conserved as an orthologous element in mice (Kaufman
et al., 2009). However, details of the PWS-IC imprinting mecha-
nism in mice have recently emerged, showing that transcription
through the Snrpn promoter from upstream exons (U-exons) in
oocytes brings about the DNA methylation and silencing of Snrpn
exon 1 on the maternal allele (Mapendano et al., 2006; Smith et al.,
2011). In a BAC transgenic model a subset of U-exons (contained
within a ∼100 kb region 5′ of Snrpn exon 1) caused transcription
through the PWS-IC/Snrpn promoter in growing oocytes. This
transcriptional activity led to DNA methylation at the PWS-IC in
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cis and silencing of the Snrpn lncRNA expression, i.e., establish-
ment of the maternal imprint mark. There is also evidence for the
presence of a corresponding U-exon in the human AS-IC region,
which might allow for a similar mechanism of transcription/RNA
mediated epigenetic modification (Farber et al., 1999). As with
the Gnas locus, it remains unclear whether the RNA is required
or whether the process of transcription through the Snrpn pro-
moter suffices, to establish the epigenetic/imprinting mark at the
PWS-IC (Chotalia et al., 2009; Smith et al., 2011). However, the
functional similarities in oocytes between the U-exons of Snrpn
and Nesp of the Gnas locus are evident, and it has been shown
recently that transcription is a common feature associated with
the establishment of DNA methylation in oocytes (Smallwood
et al., 2011).
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